Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 156, doi. 10.1007/s11912-009-0023-5
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2009 AND VI 11 AND IP 2
Results: 11
1
2
Perifosine: Update on a novel Akt inhibitor.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 102, doi. 10.1007/s11912-009-0016-4
- By:
- Publication type:
- Article
3
Myeloid-derived suppressor cells: A novel therapeutic target.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 87, doi. 10.1007/s11912-009-0014-6
- By:
- Publication type:
- Article
4
Axitinib treatment in patients with cytokine-refractory metastatic renal cell cancer.
- Published in:
- 2009
- By:
- Publication type:
- Report
5
Surgical salvage of cancer of the oropharynx after chemoradiation.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 151, doi. 10.1007/s11912-009-0022-6
- By:
- Publication type:
- Article
6
Jak2 inhibitors: Rationale and role as therapeutic agents in hematologic malignancies.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 117, doi. 10.1007/s11912-009-0018-2
- By:
- Publication type:
- Article
7
Angiopoietin-2: Development of inhibitors for cancer therapy.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 111, doi. 10.1007/s11912-009-0017-3
- By:
- Publication type:
- Article
8
Quality of life of oropharyngeal cancer patients treated with brachytherapy.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 143, doi. 10.1007/s11912-009-0021-7
- By:
- Publication type:
- Article
9
Sarcomas of the head and neck region.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 135, doi. 10.1007/s11912-009-0020-8
- By:
- Publication type:
- Article
10
The chemokine receptors CXCR4 and CXCR3 in cancer.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 125, doi. 10.1007/s11912-009-0019-1
- By:
- Publication type:
- Article
11
VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy.
- Published in:
- Current Oncology Reports, 2009, v. 11, n. 2, p. 94, doi. 10.1007/s11912-009-0015-5
- By:
- Publication type:
- Article